Estradiol 17-beta-dehydrogenase 2 (HSD17B2) is a microsomal enzyme expressed in osteoblastic cells (Wu et al. 1993, Dong et al. 1998). It catalyses the oxidation of highly active beta-estradiol (E2) and testosterone into the weaker 17-ketosteroids estrone (E1) and androstene-3,17-dione, respectively. Osteoporosis is a common, age-related disease characterised by a systemic impairment of bone mass, increasing bone fragility and fracture risk. A drop in E2 and testosterone levels, occurring with ageing, is the main factor driving the onset and progression of this disease. Potent inhibitors of HSD17B2 could be a novel treatment for this disease (Gargano et al. 2015).
Gargano, EM, Allegretta, G, Perspicace, E, Carotti, A, Van Koppen, C, Frotscher, M, Marchais-Oberwinkler, S, Hartmann, RW
Dong, Y, Qiu, QQ, Debear, J, Lathrop, WF, Bertolini, DR, Tamburini, PP
Wu, L, Einstein, M, Geissler, WM, Chan, HK, Elliston, KO, Andersson, S
estradiol 17-beta-dehydrogenase activity of HSD17B2 [endoplasmic reticulum membrane]
© 2021 Reactome
